Alkermes Plc
NASDAQ:ALKS
Alkermes Plc
NASDAQ:ALKS
Price:
24.23 USD
-0.94%
Market Closed
Updated:
May 17, 2024
Alkermes Plc
Research & Development
|
Alkermes Plc
Research & Development Peer Comparison
Comparables:
AMRN
PRTA
M
MURA
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Alkermes Plc
NASDAQ:ALKS
|
Research & Development
-$234.4m
|
CAGR 3-Years
16%
|
CAGR 5-Years
11%
|
CAGR 10-Years
-3%
|
|
|
Amarin Corporation PLC
NASDAQ:AMRN
|
Research & Development
-$22.1m
|
CAGR 3-Years
17%
|
CAGR 5-Years
16%
|
CAGR 10-Years
10%
|
|
|
Prothena Corporation PLC
NASDAQ:PRTA
|
Research & Development
-$239.9m
|
CAGR 3-Years
-44%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
-23%
|
|
M
|
Mural Oncology PLC
NASDAQ:MURA
|
Research & Development
-$165.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Alkermes Plc's Research & Development?
Research & Development
-234.4m
USD
-234.4m
USD
Based on the financial report for Mar 31, 2024, Alkermes Plc's Research & Development amounts to -234.4m USD.
What is Alkermes Plc's Research & Development growth rate?
Research & Development CAGR 10Y
-3%
-3%
Over the last year, the Research & Development growth was 38%. The average annual Research & Development growth rates for Alkermes Plc have been 16% over the past three years , 11% over the past five years , and -3% over the past ten years .
You don't have any saved screeners yet
